Ziacom Groupa company owned by the private equity fund Suma Capital and focused on dental solutions, continues making purchases abroad. The dental solutions company has closed the acquisition of the majority of two companies in Ecuador and Portugal, Safe Implant and Lusobionicrespectively, as explained by the company. Both transactions, which join the first international operation signed in Italy with two other integrations.
The purchase of Safe Implant reinforces Ziacom’s positioning as a key player in emerging countries such as Ecuador, Colombia and Peru with a growing demand in dental implantology. The company has been doubling its sales for several years and with the support of the Spanish company, it hopes to exceed one million dollars in turnover in its key markets before 2026.for which the Spanish company has planned a significant injection of resources. The agreement requires that the founder Klever Torres maintain a significant participation and lead the management of the commercial team.
Regarding the purchase of Lusobionic, the operation reinforces the growth strategy in the Iberian Peninsula by expanding its distribution capacity and consolidating its offer of innovative solutions in the dental field.
In Portugal, where Ziacom already operated, the distribution capacity in the country is significantly expanded. Lusobionic, which has experienced notable growth in recent years in the Portuguese market, as well as in central and northern Spain, joins and will integrate into its commercial team and client portfolio. This will allow its clients to access a comprehensive portfolio of high-quality oral solutions, thus consolidating Ziacom Group’s commitment to innovation and oral health.
Various acquisitions
With these operations, Ziacom has already acquired four companies so far this year. The purchasing battery began in Italy, where the purchase of ITS and Ubgen was signed. ITS was founded in 2004 by Marco Manno, while the second was created in 2013 by Ilenia Geretto. Both have a solid track record and extensive experience in the development of innovative and high-quality products for the dental sector.
The growth stage coincides with the entry of Suma Capital into the shareholding, which has taken the company to 20 million in revenue from the 11 million it had before its arrival. The private equity fund took 40% of the company through SC Growth Fund II, a vehicle for growth capital with a strong focus on ESG.
#Suma #Capital #fattens #dental #company #Ziacom #purchases #Portugal #Ecuador